We advise through the entire development and life cycle of a medical device. Our work usually opens with determining whether a product is a device or not, device classification and a gap analysis against the MDR, followed by a practical roadmap to full compliance. From there we advise on clinical evaluation reports, classification rationales, risk management files and the technical documentation notified bodies expect to see, and we guide you through the conformity assessment procedure itself where needed. Once a device is on the market, we help build or refine post-market surveillance, vigilance and post-market clinical follow-up. When a field safety corrective action or recall needs to be considered, we move quickly — as we do when a competent authority raises questions or opens an investigation. We advise, too, on labelling, on interactions with healthcare professionals and the rules on inducements, and on clinical investigation requirements. And we support hospitals and research institutions that manufacture devices in-house, as well as assessing regulatory exposure in M&A due diligence.